Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP207285.RADdhwxesb0rjqwxJ5MpIfjfKKkL1tnyowIqOaFEVKAQc130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207285.RADdhwxesb0rjqwxJ5MpIfjfKKkL1tnyowIqOaFEVKAQc130_provenance.
• assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP433563.RAnS1zcQMwEcWeiXLOupMMBG4_EhgkDdOSU-qEq3jtlP8130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433563.RAnS1zcQMwEcWeiXLOupMMBG4_EhgkDdOSU-qEq3jtlP8130_provenance.
• NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.
• NP643029.RAAPq2HcduDYu5szDmqPJVsWnGS-VAjxLsUExQeQlro7M130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643029.RAAPq2HcduDYu5szDmqPJVsWnGS-VAjxLsUExQeQlro7M130_provenance.
• NP654497.RA9DtYrOrKBYbGN8nJnbtPFL8jf_ZN-EcL8H0rAGPg9oM130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654497.RA9DtYrOrKBYbGN8nJnbtPFL8jf_ZN-EcL8H0rAGPg9oM130_provenance.
• NP822927.RACfbX2Ng0Jx_L1XGOIKCArsdGWcthN2KDjShzkRscuaw130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822927.RACfbX2Ng0Jx_L1XGOIKCArsdGWcthN2KDjShzkRscuaw130_provenance.
• NP608061.RAf5Cumb5LGm5Vf2Eja6D4IJbZxYqIkvL6VAI6-AUHbeQ130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608061.RAf5Cumb5LGm5Vf2Eja6D4IJbZxYqIkvL6VAI6-AUHbeQ130_provenance.
• NP643131.RAZRRbWgW_YJYEAao6F-6p0MjbHtKII7_B25HRsVeY9tc130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643131.RAZRRbWgW_YJYEAao6F-6p0MjbHtKII7_B25HRsVeY9tc130_provenance.
• NP608180.RAzwPlQZExjuaJ_KjxVsail2IiK2dRIzcq_EwaN2IVPiA130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608180.RAzwPlQZExjuaJ_KjxVsail2IiK2dRIzcq_EwaN2IVPiA130_provenance.
• NP822926.RAzI1Z2Zf3AKWVckiGA0FKE1_QhBB1B-ZfBs-GygSDdG8130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822926.RAzI1Z2Zf3AKWVckiGA0FKE1_QhBB1B-ZfBs-GygSDdG8130_provenance.
• NP822928.RAwW5YO_5c3Rzaz1opg2-H8dpJ-TdCwjhUJ5Cj0nzgChA130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822928.RAwW5YO_5c3Rzaz1opg2-H8dpJ-TdCwjhUJ5Cj0nzgChA130_provenance.
• NP822937.RA_QfdicWbnKqkCZmcutpFJeQY7jc8Yxox5Z1ghbcQoOQ130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822937.RA_QfdicWbnKqkCZmcutpFJeQY7jc8Yxox5Z1ghbcQoOQ130_provenance.
• NP822938.RA8Ao0hMRFbA5hmggFGA17k-mLyC6eMCDt-mZ9LvS8E80130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822938.RA8Ao0hMRFbA5hmggFGA17k-mLyC6eMCDt-mZ9LvS8E80130_provenance.
• assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP822933.RAY2Ufz1J_EopjfsvBNd2RCBevnHA-W6h9O444s-tJIxI130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822933.RAY2Ufz1J_EopjfsvBNd2RCBevnHA-W6h9O444s-tJIxI130_provenance.
• NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.
• NP822939.RAaYKHvDCxnibeQ8GIpzsUig8wK0_L2EBh8xT9yoqWK6U130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822939.RAaYKHvDCxnibeQ8GIpzsUig8wK0_L2EBh8xT9yoqWK6U130_provenance.
• NP822932.RAk8zx1AXSr-fMaRGbLDM-pAl-IyGGCVKkaG5jV9Yu3nM130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822932.RAk8zx1AXSr-fMaRGbLDM-pAl-IyGGCVKkaG5jV9Yu3nM130_provenance.
• NP822936.RAtANJSCSf_e8eqdfLX0SQ9AB79YQGQZfm373lFJPsWPg130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822936.RAtANJSCSf_e8eqdfLX0SQ9AB79YQGQZfm373lFJPsWPg130_provenance.